{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:18:32Z","timestamp":1773289112182,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s13277-014-2984-8","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T18:44:28Z","timestamp":1422038668000},"page":"3483-3488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cancer-associated fibroblasts promote renal cell carcinoma progression"],"prefix":"10.1007","volume":"36","author":[{"given":"Yunze","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiran","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"issue":"4","key":"2984_CR1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.eururo.2011.06.049","volume":"60","author":"B Ljungberg","year":"2011","unstructured":"Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60(4):615\u201321.","journal-title":"Eur Urol"},{"issue":"7","key":"2984_CR2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1541-7786.MCR-12-0117","volume":"10","author":"E Jonasch","year":"2012","unstructured":"Jonasch E, Futreal A, Davis I, Bailey S, Kim WY, Brugarolas J, et al. State-of-the-science: an update on renal cell carcinoma. Mol Cancer Res. 2012;10(7):859\u201380.","journal-title":"Mol Cancer Res"},{"key":"2984_CR3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0094-0143(03)00056-9","volume":"30","author":"NK Janzen","year":"2003","unstructured":"Janzen NK, Kim HL, Figlin RA. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003;30:843\u201352.","journal-title":"Urol Clin North Am"},{"key":"2984_CR4","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1158\/1078-0432.CCR-08-0504","volume":"14","author":"Z Jiang","year":"2008","unstructured":"Jiang Z, Chu PG, Woda BA, Liu Q, Balaji KC, Rock KL, et al. Combination of quantita-tive IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas. Clin Cancer Res. 2008;14:5579\u201384.","journal-title":"Clin Cancer Res"},{"key":"2984_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/cncr.24713","volume":"116","author":"S Patil","year":"2010","unstructured":"Patil S, Ishill N, Deluca J, Motzer RJ. Stage migration and increasing proportion of favor-able-prognosis metastatic renal cell carcinoma patients: implications for clinical trial designand interpretation. Cancer. 2010;116:347\u201354.","journal-title":"Cancer"},{"issue":"2","key":"2984_CR6","first-page":"221","volume":"1845","author":"M Santoni","year":"2014","unstructured":"Santoni M, Pantano F, Amantini C, Nabissi M, Conti A, Burattini L, et al. Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma. Biochim Biophys Acta. 2014;1845(2):221\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"2984_CR7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.18632\/oncotarget.188","volume":"1","author":"B Markman","year":"2010","unstructured":"Markman B, Dienstmann R, Tabernero J. Targeting the PI3K\/Akt\/mTOR pathway beyond rapalogs. Oncotarget. 2010;1:530\u201343.","journal-title":"Oncotarget"},{"key":"2984_CR8","doi-asserted-by":"crossref","unstructured":"Tlsty T. Cancer: whispering sweet somethings. Nature. 2008;29;453(7195):604\u20135.","DOI":"10.1038\/453604a"},{"key":"2984_CR9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1476-4598-9-168","volume":"9","author":"S Haubeiss","year":"2010","unstructured":"Haubeiss S, Schmid JO, M\u00fcrdter TE, Sonnenberg M, Friedel G, van der Kuip H, et al. Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010;9:168.","journal-title":"Mol Cancer"},{"key":"2984_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.pathol.1.110304.100224","volume":"1","author":"TD Tlsty","year":"2006","unstructured":"Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol. 2006;1:119\u201350.","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"2984_CR11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392\u2013401.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2984_CR12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1158\/0008-5472.CAN-07-5714","volume":"68","author":"RF Hwang","year":"2008","unstructured":"Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68(3):918\u201326.","journal-title":"Cancer Res"},{"key":"2984_CR13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1593\/tlo.12349","volume":"6","author":"T Hellevik","year":"2013","unstructured":"Hellevik T, Pettersen I, Berg V, Bruun J, Bartnes K, Busund LT, et al. Changes in the secretory profile of NSCLC-associated fibroblasts after ablative radiotherapy: potential impact on angiogenesis and tumor growth. Transl Oncol. 2013;6:66\u201374.","journal-title":"Transl Oncol"},{"key":"2984_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6:17\u201332.","journal-title":"Cancer Cell"},{"issue":"2","key":"2984_CR15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ctrv.2013.09.003","volume":"40","author":"R Iacovelli","year":"2014","unstructured":"Iacovelli R, Alesini D, Palazzo A, Trenta P, Santoni M, De Marchis L, et al. Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials. Cancer Treat Rev. 2014;40(2):271\u20135.","journal-title":"Cancer Treat Rev"}],"updated-by":[{"DOI":"10.1007\/s13277-017-5487-6","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"record-id":"7239"},{"DOI":"10.1007\/s13277-017-5487-6","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000}}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2984-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2984-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2984-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T01:56:54Z","timestamp":1566266214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2984-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2984"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2984-8","relation":{"retraction":[{"id-type":"doi","id":"10.1007\/s13277-017-5487-6","asserted-by":"object"}]},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,23]]}}}